Hypertension Induced by Aripiprazole Use in an Autistic Child Patient
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Atypical antipsychotics in children and adolescents are widely used for aggression, emotional variability and psychosis treatment. Aripiprazole is also an atypical antipsychotic that increasingly used in children and adolescents with schizophrenia, autism and bipolar disorder. In this case report, a medically healthy patient with autism associated with behavioral problems is presented with the development of hypertension after the onset of aripiprazole and the return of blood pressure to normal levels after withdrawal of the drug. The purpose of this case study is to discuss and report the emergence of aripiprazole-induced hypertension as a side effect of drugs in children and adolescents.
Abstract
Atypical antipsychotics in children and adolescents are widely used for aggression, emotional variability and psychosis treatment. Aripiprazole is also an atypical antipsychotic that increasingly used in children and adolescents with schizophrenia, autism and bipolar disorder. In this case report, a medically healthy patient with autism associated with behavioral problems is presented with the development of hypertension after the onset of aripiprazole and the return of blood pressure to normal levels after withdrawal of the drug. The purpose of this case study is to discuss and report the emergence of aripiprazole-induced hypertension as a side effect of drugs in children and adolescents.
참고문헌 (15)
- Goel R, "An update on pharmacotherapy for autism spectrum disorder in children and adolescents", Int Rev Psychiatry, 30, pp.78~95 (2018)
- National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents, "The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents", Pediatrics, 114, pp.555~576 (2004)
- Borras L, "Hypertension and aripiprazole", Am J Psychiatry, 162, pp.2392~ (2005)
- Bat-Pitault F, "Aripiprazole and hypertension in adolescents", J Child Adolesc Psychopharmacol, 19, pp.601~602 (2009)
- Pitchot W, "Aripiprazole, hypertension, and confusion", J Neuropsychiatry Clin Neurosci, 22, pp.123~ (2010)
- Hsiao YL, "Aripiprazole augmentation induced hypertension in major depressive disorder : a case report", Prog Neuropsychopharmacol Biol Psychiatry, 35, pp.305~306 (2011)
- Yasui-Furukori N, "Worsened hypertension control induced by aripiprazole", Neuropsychiatr Dis Treat, 9, pp.505~507 (2013)
- Seven H, "Aripiprazoleinduced asymptomatic hypertension : a case report", Psychopharmacol Bull, 47, pp.53~56 (2017)
- Correll CU, "Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents", J Am Acad Child Adolesc Psychiatry, 45, pp.771~791 (2006)
- Laita P, "Antipsychotic-related abnormal involuntary movements and metabolic and endocrine side effects in children and adolescents", J Child Adolesc Psychopharmacol, 17, pp.487~502 (2007)
- Yegül Gülnar G, "Obesity-related hypertension mechanisms in children and adolescents", İzmir Katip Çelebi Univ Fac Health Sci J, 2, pp.39~43 (2017)
- Stahl SM, "Stahl’s essential psychopharmacology: neuroscientific basis and practical applications" (2013), Cambrigde University Press
- Davies MA, "Aripiprazole : a novel atypical antipsychotic drug with a uniquely robust pharmacology", CNS Drug Rev, 10, pp.317~336 (2004)
- Shapiro DA, "Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology", Neuropsychopharmacology, 28, pp.1400~1411 (2003)
- Kato T, "Inhibitory effects of aripiprazole on interferon‐‐induced microglial activation via intracellular Ca2+ regulation in vitro", J Neurochem, 106, pp.815~825 (2008)